Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
720 participants
INTERVENTIONAL
2025-04-28
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impacts of Alcohol Warning Labels: An Online Experiment
NCT06442800
Mobile Alcohol Use Intervention
NCT07126613
Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
NCT04286867
Impact of Alcohol Labels in a Real-World Setting
NCT06915298
Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information
NCT05873556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After providing informed consent, participants will be randomly assigned to receive new front-of-package health warnings or control labels.
Participants will attend 3 in-person study visits spaced approximately 1 week apart. Participants in the warnings arm will receive a health warning applied to the front of their alcohol containers at each of the weekly visits for a total of 3 unique warnings during the study. Warnings will be applied in counterbalanced order. Participants in the control arm will receive one label during the study.
Participants will report the number of drinks they consumed daily via text message and will complete 4 computer surveys spaced approximately 1 week apart.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Front-of-package health warning
Front-of-package health warning
Participants will receive 3 different health warnings about alcohol consumption. The warnings will discuss health risks of alcohol including cancer, high blood pressure, and scarring of the liver. Labels will be placed on the front of participants' alcohol containers.
Control label
Control label
Participants will receive a label displaying a barcode. Labels will be placed on the front of participants' alcohol containers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Front-of-package health warning
Participants will receive 3 different health warnings about alcohol consumption. The warnings will discuss health risks of alcohol including cancer, high blood pressure, and scarring of the liver. Labels will be placed on the front of participants' alcohol containers.
Control label
Participants will receive a label displaying a barcode. Labels will be placed on the front of participants' alcohol containers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not identified as having possible alcohol dependence
* Consumed alcohol at least once per week during the past 4 weeks
* At least half of alcohol consumed each week is from store-bought containers
* Willing to bring 8 days' worth of alcohol to 3 in-person study visits
* Not pregnant, breastfeeding, or trying to get pregnant
* Able to take surveys in English
* Willing to respond to text messages daily for 3 weeks
* Not living in the same household as anyone else in the study
Exclusion Criteria
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marissa Hall, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC study office
Chapel Hill, North Carolina, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-1218b
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.